IP Verse

Ascendis Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Ascendis Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3175863	Variants Of C-Type Natriuretic Peptide	BIOMARIN PHARMACEUTICAL	Apr 10, 2025
EP3175863	Variants Of C-Type Natriuretic Peptide	BIOMARIN PHARMACEUTICAL	Sep 1, 2022

Explore the latest publications and patents granted to Ascendis Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Ascendis Pharma
EP2512450	Feb 7, 2018	Dry Growth Hormone Composition Transiently Linked To A Polymer Carrier	No Opposition Filed Within Time Limit

Discover the latest PTAB cases involving Ascendis Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Ascendis Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ASCENDIS PHARMA GROWTH DISORDERS	1	-	-	-
BIOMARIN PHARMACEUTICAL	-	18	3	-